Business
DECN CEO Interviewed On Vancouver's #1 News/Talk Radio Station, Discusses GenViro! Covid-19 :15 Swift Test Kit, Additional Interviews Anticipated
DECN CEO Interviewed On Vancouver's #1 News/Talk Radio Station, Discusses GenViro! Covid-19 :15 Swift Test Kit, Additional Interviews Anticipated.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"LOS ANGELES, CA / ACCESSWIRE / June 4, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc. today made available CEO Keith Berman's recent interview on radio station CKNW, Vancouver's #1 rated News/Talk Radio station in the adult 35-64 sector. Berman appeared LIVE with talk show host John Daly on his "Daly Back on the Beat," Show and discussed the Decision Diagnostics GenViro! Covid-19 :15 Swift Kit testing kit. You can listen to the full interview here at:https://app.criticalmention.com/app/#/report/0d5e3e82-8ecd-4ac6-aa2b-cfa28f08fb5dThe company had previously announced that separate Emergency Use Applications (EUA) had been filed for its GenViro! Professional use and GenViro! at-home use test kits which are currently before the FDA for their review. In addition, the company will shortly update its web site with additional testing data. The provision of previous information provided was taken down due to unauthorized publication of the data password. Additional testing data is due to us in the next several days and will be reviewed and posted. We are currently searching for methods to make this data more secure.Decision Diagnostics through its Pharma Tech Solutions, Inc. subsidiary is an 18-year old diabetes testing firm, high-level manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for its own proprietary regulated medical devices. Subject to FDA authorization of its GenViro! Swift kits, DECN anticipates adopting its further developed impedance technology, first utilized for its diabetic testing products and distribution networks, to implement the manufacturing and distribution of its GenViro! Covid-19 :15 Swift test kits in the U.S., Canada, and worldwide.Keith Berman, CEO of Decision Diagnostics Corp. commented, "We will continue working toward an FDA authorized EUA for our GenViro! Swift :15 second testing kits for both professional use and application, and also for at-home use. Media interest such as this demonstrated by a well-respected news/talk station such as CKNW as well as WCBS-TV helps support our contention that we have developed a unique testing kit and we hope to be in a position to provide additional media interviews in the coming w...